amylin vs glp-1 Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Identification and utility exploration of

Clinical Outcomes Weight and glucose outcomes with both agents have been impressive, but many studies show greater weight loss and A1C reduction with Mounjaro compared with GLP-1only therapies

Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model

Ethics statement All experimental procedures were approved by the Ethical Committee of the Faculty of Veterinary Medicine of the University of Ghent, Belgium (approval number EC2011-113) and carried out in accordance with the approved guidelines and regulations

Months 12: Building Metabolic Effects Metabolic changes are building but may not yet be visible in symptoms or lab work